Prof. Dr. Ozcan YILDIZ

Prof. Dr. Ozcan YILDIZ
Biruni Üniversitesi Tıp Fakültesi Hastanesi
Biruni Üniversitesi Tıp Fakültesi Hastanesi
/
İstanbul
Make an Appointment
444 8 276

Medical Interests

  • Lung cancer
  • Breast cancer
  • Stomach cancer
  • Neuroendocrine tumors
  • Colorectal cancer
  • Pancreatic cancer
  • Prostate cancer
  • Bladder cancer
  • Kidney cancer
  • Brain tumors
  • Bone and soft tissue cancers
  • Interpretation of genetic tests in oncology.

Questions related to Medical Oncology

Resume

Education

  • İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi (İngilizce Tıp) — 1988–1995
  • Sağlık Bakanlığı Taksim Eğitim ve Araştırma Hastanesi, İç Hastalıkları Uzmanlık Eğitimi — 1996–2001
  • İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Tıbbi Onkoloji Yan Dal Uzmanlık Eğitimi — 2003–2006

Experience

  • Düzce Üniversitesi, İç Hastalıkları Anabilim Dalı, Yrd. Doçent — 2001–2008
  • Bursa Ali Osman Sönmez Onkoloji Hastanesi, Uzman Doktor — 2008–2010
  • İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Tıbbi Onkoloji Bilim Dalı, Doçent — 2010–2012
  • İstanbul Medipol Üniversitesi, Tıbbi Onkoloji Anabilim Dalı, Profesör — 2012–2025
  • Biruni Üniversitesi, Tıbbi Onkoloji Anabilim Dalı, Profesör — 2025–
  • Toronto Üniversitesi, Princess Margaret Kanser Merkezi, Klinik Fellow — 2007

Languages

  • İngilizce (İleri düzey)

Fee Information

Call to learn examination fees.

444 8 276

Payment Methods

  • Cash
  • Credit Card
  • Bank Transfer

Addresses

Call Center

444 8 276

Call

Address

Biruni Üniversitesi Tıp Fakültesi Hastanesi, Gültepe, Halkalı Cd No: 99, 34295 Küçükçekmece/İstanbul, İstanbul, Türkiye

Scientific Publications

Scientific Memberships

  • ESMO (Avrupa Tıbbi Onkoloji Derneği)
  • ASCO (Amerikan Klinik Onkoloji Derneği)

Publications

  • 1. Ataoglu S, Ozcetin A, Yildiz O, Ataoglu A. Evaluation of dexamethasone suppression test in fibromyalgia patients with or without depression Swiss Med Wkly. 2003: 19;133: 241-4.
  • 2. Akcan Y, Bayraktar Y, Arslan S, Van Thiel DH, Zerrin BC, Yildiz O.The Importance of Serial Measurements of cytokine Levels for the Evaluation of their Role In Pathogenesis in Familial Mediterranean Fever. Eur J Med Res. 2003 Jul 31; 8:304-6.
  • 3. Yazici M, Gorgulu S, Sertbas Y, Erbilen E, Albayrak S, Yildiz O, Uyan C. Effects of thyroxin therapy on cardiac function in myocardial performance in the evaluation of left ventricular function. Int J Cardiol. 2004; 95:135-43.
  • 4. Yildiz O, Ozguroglu, M. Idiopathic thrombocytopenia associated with dysgerminoma in a patient with androgen insensitivity syndrome. Gynecol Oncol. 2005; 99:248.
  • 5. Sahin I, Oksuz S, Sencan I, Gulcan A, Karabay O, Gulcan E, Yildiz O. Prevalance and risk factors for yeast colonization in adult diabetic patients. Ethiop Med J. 2005; 43:103-9.
  • 6. Ozguroglu M, Yildiz O, Turna H, Kadioğlu P.Megestrol acetate induced
  • hypoadrenalism with cushingoid phenotype in endometrial cancer. Gynecol Oncol. 2006; 101:183.
  • 7. Ateser G, Yildiz O, Leblebici C, Mandel NM, Unal F, Turna H, Arikan I, Colcaki D. Metastatic Primitive Neuroectodermal Tumor of the Ovary in Pregnancy.Int J Gynecol Cancer. 2007 Jan-Feb; 17:266-9.
  • 8. Yildiz O, Ozguroglu M, Yanmaz MT, Turna H, Kursunoglu SG, Antonov M, Serdaroglu S, Demirkesen C, Buyukunal E Paraneoplastic Pemphigus Associated with fludarabine use. Med Oncol. 2007; 24:115-8.
  • 9. Yildiz O, Ozguroglu M, Turna H, Yanmaz T, Kaynak K, Akman C, Cetin SE, Oz B Celik A. Thymoma with chronic diarrhea: report of two cases and review of the literature. Med Oncol. 2007; 24:119-23.
  • 10. Kanat M, Sipahioglu M, Arinc H, Serin E, Yildiz O, Tunckale A, Celebi H.Is lipid lowering treatment aiming for very low LDL levels safe in terms of the synthesis? Med. Hypotheses. 2007;69(1):104-12. Epub 2007 Jan 17.
  • 11. Ozcetin A, Ataoglu S, Kocer E, Yazici S, Yildiz O, Ataoglul A, Icmeli C. Effects of depression and anxiety on quality of life of patients with rheumatoid arthritis, knee osteoarthritis and fibromyalgia syndrome. West Indian Med J. 2007 Mar;56(2):122-9.
  • 12. Yildiz O, Ozguroglu M. Gastroenteropancreatic neuroendocrine tumors: 10 year experience in a single center. Med Oncol. 2010 Dec; 27:1050-6.
  • 13. Yuruyen M, Yildiz O. Gestational choriocarcinoma diagnosed with spontaneous splenic rupture after pregnancy induced by in vitro fertilization: a case report. Cases J. 2009 May; 152:7518.
  • 14. Papila B, Yildiz O, Tural D, Delil S, Hasiloglu ZI, Ayan F, Papila C. Wernicke's Encephalopathy in Colon Cancer. Case Rep Oncol. 2010 Oct 9;3(3):362-7.
  • 15. Kanat M, Serin E, Tunckale A, Yildiz O. A multi-center, open label, crossover designed prospective study evaluating the effects of lipid lowering treatment on steroid synthesis in patients with Type 2 diabetes (MODEST Study). J Endocrinol Invest. 2009 Nov;32(10):852-6. Epub 2009 Sep 11.
  • 16. Yildiz O, Buyuktas D, Ekiz E, Selcukbiricik F, Papila I, Papila C. Facial nerve palsy: an unusual presenting feature of small cell lung cancer. Case Rep Oncol. 2011 Jan 25;4(1):35-8.
  • 17. Yildiz O, Serdengecti S. Neuroendocrine Tumor. Gastrointestinal carcinoids. ISBN 979-953-307-167-0. ISRN Oncol. 2011;2011: 451086. doi: 10.5402/2011/451086. Epub 2011 Jun 20.
  • 18. Tural D, Yildiz O, Selcukbiricik F, Ozturk MA, Keles Y, Oz B, Uzel O, Demir G, Mandel NM. Olfactory neuroblastomas: an experience of 24 years. ISRN Oncol. 2011;2011: 451086.
  • 19. Tural D, Selcukbiricik F, Özturk MA, Yildiz O, Turna H, Erdamar S, Büyükünal E, Serdengeçti S. The relation between pathological complete response and clinical out come in patients with rectal cancer. Hepatogastroenterology. 2013;60:1365-70.